Total Payments
$844.32
2024 Payments
$844.32
Companies
21
Transactions
31
Payment Breakdown by Category
Food & Beverage$650.32 (77.0%)
Education$194.00 (23.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $650.32 | 29 | 77.0% |
| Education | $194.00 | 2 | 23.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $200.90 | 6 | $0 (2024) |
| SOBI, INC | $160.96 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $40.56 | 2 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $34.72 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $33.92 | 2 | $0 (2024) |
| BeiGene USA, Inc. | $33.05 | 1 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $31.14 | 1 | $0 (2024) |
| Eisai Inc. | $28.84 | 1 | $0 (2024) |
| PharmaEssentia USA Corporation | $28.42 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $28.19 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $844.32 | 31 | Janssen Biotech, Inc. ($200.90) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Oncology | ||||||
| 12/23/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: ONC | ||||||
| 12/16/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Oncology | ||||||
| 12/12/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 12/05/2024 | SOBI, INC | DOPTELET (Drug) | Education | In-kind items and services | $95.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| 11/27/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Oncology | ||||||
| 11/19/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/15/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.30 | General |
| Category: Hematology/Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.37 | General |
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Oncology | ||||||
| 11/04/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $34.72 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 10/28/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Oncology | ||||||
About Samuel Marino, NP
Samuel Marino, NP is a Acute Care healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2024. The National Provider Identifier (NPI) number assigned to this provider is 1932922606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samuel Marino, NP has received a total of $844.32 in payments from pharmaceutical and medical device companies, with $844.32 received in 2024. These payments were reported across 31 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($650.32).
Ad
Practice Information
- Specialty Acute Care
- Location Riverside, CA
- Active Since 11/01/2024
- Last Updated 11/01/2024
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1932922606
Products in Payments
- RYBREVANT (Drug) $145.61
- DOPTELET (Drug) $119.78
- SYNAGIS (Drug) $41.18
- Rezlidhia (Drug) $34.72
- TEVIMBRA (Drug) $33.05
- TECVAYLI (Biological) $32.32
- LONSURF (Drug) $31.14
- Lenvima (Drug) $28.84
- BESREMI (Drug) $28.42
- IMFINZI (Biological) $28.19
- XPOVIO (Drug) $26.57
- JAKAFI (Drug) $25.30
- ERLEADA (Drug) $22.97
- SARCLISA (Biological) $21.64
- LOQTORZI (Biological) $21.35
- IMBRUVICA (Drug) $18.86
- Stivarga (Drug) $17.19
- Nubeqa (Drug) $16.73
- LIBTAYO (Biological) $16.14
- Trodelvy (Drug) $15.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Riverside
Mary Whittenhall
Acute Care — Payments: $18,334
Acute Care $18,334
Kelly Owen
Acute Care — Payments: $12,439
Acute Care $12,439
Helia Wilmott, Nurse Practitioner, NURSE PRACTITIONER
Acute Care — Payments: $1,173
Acute Care $1,173
Lorena Ruiz, Ag-Acnp, AG-ACNP
Acute Care — Payments: $832.39
Acute Care $832.39
Hong Tran, Np, NP
Acute Care — Payments: $752.48
Acute Care $752.48
Mrs. Veronica Delgado, Np, NP
Acute Care — Payments: $298.83
Acute Care $298.83